<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "eptifibatide inj VIAL>
<dose><value>180</value>
<value>2</value>
<value>1</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>eptifibatide inj VIAL</value>
</drugname><strength><value>0.75 mg/mL</value>
<value>2 mg/mL</value>
</strength><frequency><value>ONCE</value>
<value>CONTINUOUS</value>
</frequency><instruction><value>Loading dose. ( Maximum dose: 22.6 mg)</value>
<value>Administer by continuous infusion, up to 72 hours</value>
<value>Adjust infusion if creatinine greater than 175 - 250 mol/L</value>
<value>Second loading dose administered 10 minutes after first loading dose in patients undergoing PCI. ( Maximum dose: 22.6 mg)</value>
</instruction><volume><value>100 mL</value>
<value>10 mL</value>
</volume><units><value>mcg/kg</value>
<value>mcg/kg/minute</value>
</units><additionalnotes><value></value>
<value>Maximum infusion rate: 15 mg/hour</value>
</additionalnotes><population><value></value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value></value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary with Restrictions, Usage guidelines.</value>
</ahsformularystatus><ahfsname><value>Antithrombotic Agents, Platelet-Aggregation Inhibitors</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose><value>YES</value>
</maximumprndose></drug>